InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
6
T+90 hit rate
60%
T+90 mean return
-11.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Vazzano Joseph Walter, Chief Financial Officer. Director active across 2 companies, notably Avenue Therapeutics, INC.. In total, 26 filings have been logged. Split: 3 buys · 6 sells. Total volume traded: €54k. History available since 15 September 2021. The latest transaction was disclosed on 20 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations26 total
10,271 sharesCommon StockSEC:0001493152-26-028022:0
13,421 sharesCommon StockSEC:0001493152-26-028022:1
25,646 sharesCommon StockSEC:0001493152-26-028022:2
133,595 shares0Common StockSEC:0001493152-26-002889:0
1,502 shares@ US$6.64094.7% of flowCommon StockSEC:0001641172-25-020575:0
685 shares@ US$5.291.9% of flowCommon stockSEC:0001493152-25-010591:0
144,509 shares0Common stockSEC:0001493152-25-003464:0
6,388 shares@ US$5.8918.8% of flowCommon stockSEC:0001493152-24-038799:0
1,055 shares@ US$5.112.8% of flowCommon stockSEC:0001493152-24-028697:0
155,200 shares0Common stockSEC:0001493152-24-026648:0
16,408 shares@ US$4.5238.1% of flowCommon stockSEC:0001493152-24-023125:0
5,608 shares@ US$3.149.2% of flowCommon stockSEC:0001493152-24-016062:0
Ideal exit: 20 Jan 2025 (T+270)
703 shares@ US$8.142.9% of flowCommon stockSEC:0001493152-24-010132:0
6,230 shares@ US$3.9359.7% of flowCommon stockSEC:0001493152-23-034904:0
14 shares@ US$3.700.1% of flowCommon stockSEC:0001493152-23-033142:0
Ideal exit: 15 Jun 2024 (T+270)
1,187 shares@ US$3.732.2% of flowCommon stockSEC:0001493152-23-025515:0
141,908 shares0Common stockSEC:0001493152-23-020416:0
792 shares@ US$2.601.1% of flowCommon stockSEC:0001493152-23-008076:0
2,500 shares@ US$4.005.4% of flowCommon stockSEC:0001493152-22-033018:0
Ideal exit: 15 Aug 2023 (T+270)
72,750 shares0Common stockSEC:0001493152-22-027277:0
12,000 shares0Common stockSEC:0001493152-22-020281:0
200,000 shares0Common stockSEC:0001493152-22-006976:0
100,505 shares0Common StockSEC:0001104659-21-151771
100,505 shares0Common StockSEC:0001104659-21-151771:0
7,160 shares@ US$1.620.45% mcap50.0% of flowCommon StockSEC:0001104659-21-115916:0
25 of 26 declarations
About Vazzano Joseph Walter
Joseph Walter Vazzano serves as the Chief Financial Officer at Avenue Therapeutics, Inc. and Abeona Therapeutics Inc. In this role, he is responsible for managing the finances of both companies, which specialize in developing treatments for rare diseases. Joseph plays a key role in financial planning and funding strategy. His financial expertise is essential for ensuring the growth and sustainability of the companies.
